ATLANTA—Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University… more »
ABU DHABI– Despite clear evidence of the damage that smoking does to human health, the tobacco industry is expanding its sales in low- and middle-income countries across the globe, increasing the burden of chronic health problems in the poorest nations, according to the newly released fifth edition of The Tobacco Atlas.
The Atlas, released on… more »
ATLANTA—Dr. Ming-Hui Zou, an internationally recognized researcher in molecular and translational medicine at the University of Oklahoma Health Science Center, has been named the founding director of the new Center for Molecular and Translational Medicine at Georgia State University.
He is also a Georgia Research Alliance (GRA) Eminent Scholar in Molecular Medicine, becoming the seventh… more »